Process for preparation of dronedarone by Grignard reaction

US9238636B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9238636-B2
Application numberUS-201314403528-A
CountryUS
Kind codeB2
Filing dateMay 23, 2013
Priority dateMay 31, 2012
Publication dateJan 19, 2016
Grant dateJan 19, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a novel process for the preparation of dronedarone (I) and pharmaceutically acceptable salts thereof, which comprises reacting of compound of formula (IV) with compound of formula (VI) in a Grignard reaction, and the obtained product is isolated and, if desired, converted into a pharmaceutically acceptable salt thereof. The invention also relates to some novel intermediary compounds and processes for the preparation thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for the preparation of dronedarone (I) or a pharmaceutically acceptable salt thereof, comprising the steps of: a) reacting a compound of formula (IV) wherein X is Cl or Br, with a compound of formula (VI) or a salt thereof, in a Grignard reaction, wherein R is a group of formula —NR 1 R 2 , wherein R 1 and R 2 are independently selected from the group consisting of H, alkyl, alkyloxy and aryl; b) isolating dronedarone (I); and c) optionally converting dronedarone (I) into a pharmaceutically acceptable salt thereof. 2. A compound of formula (VI), or a salt thereof, wherein R is a group of formula —NR 1 R 2 , wherein R 1 and R 2 are independently selected from the group consisting of H, alkyl, alkyloxy and aryl. 3. A process for the preparation of the compound of formula (VI)) or a salt thereof, comprising the steps of: a) reacting a compound of formula (V) or a salt thereof, with an amine of formula H—R, or a salt thereof, in a solvent or in a mixture of solvents, wherein R is a group of formula —NR 1 R 2 , wherein R 1 and R 2 are independently selected from the group consisting of H, alkyl, alkyloxy and aryl; b) isolating the compound of formula (VI); and c) optionally converting the compound of formula (VI) into a salt thereof. 4. A compound of formula (IV) wherein X is Cl or Br. 5. A process for the preparation of the compound of formula (IV) comprising reacting a compound of formula (III) with Mg in an anhydrous solvent, wherein X is Cl or Br. 6. A compound of formula (III) wherein X is Cl or Br. 7. A process for the preparation of the compound of formula (III) wherein X is Cl or Br, comprising halogenating a compound of formula (II) 8. The process of claim 1 further comprising a process for the preparation of the compound of formula (IV), wherein: a compound of formula (II) is halogenated to obtain a compound of formula (III) wherein X is Cl or Br; and the obtained compound (III) is converted into the compound of formula (IV); and further comprising a process for the preparation of the compound of formula (VI), wherein: a compound of formula (V) is reacted with an amine of formula H—R, wherein R is as defined in claim 1 , to obtain the compound of formula (VI). 9. The process of claim 1 , wherein step a) further comprises an anhydrous solvent and a catalyst. 10. The process of claim 9 , wherein the solvent is THF and the catalyst is FeCl 3 . 11. The compound of claim 2 , wherein R 1 and R 2 are independently selected from the group consisting of H, methyl, ethyl, methoxy, and phenyl. 12. The process of claim 3 , wherein the solvent is dichloromethane or n-hexane and wherein step a) further comprises a catalyst. 13. The process of claim 3 , wherein the amine is selected from the group consisting of ammonia, dimethylamine, diethylamine, N,O-dimethyl hydroxylamine, and aniline. 14. The compound of claim 4 , wherein X is Cl. 15. The compound of claim 4 , wherein X is Br. 16. The compound of claim 6 , wherein X is Cl. 17. The compound of claim 6 , wherein X is Br.

Assignees

Inventors

Classifications

  • C07D307/80Primary

    Radicals substituted by oxygen atoms · CPC title

  • from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines · CPC title

  • having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals · CPC title

  • with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9238636B2 cover?
The invention relates to a novel process for the preparation of dronedarone (I) and pharmaceutically acceptable salts thereof, which comprises reacting of compound of formula (IV) with compound of formula (VI) in a Grignard reaction, and the obtained product is isolated and, if desired, converted into a pharmaceutically acceptable salt thereof. The invention also relates to some novel intermedi…
Who is the assignee on this patent?
Sanofi Sa
What technology area does this patent fall under?
Primary CPC classification C07D307/80. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).